Neurobo Pharmaceuticals Inc
NASDAQ:NRBO
Income Statement
Earnings Waterfall
Neurobo Pharmaceuticals Inc
Revenue
|
0
USD
|
Operating Expenses
|
-15.9m
USD
|
Operating Income
|
-15.9m
USD
|
Other Expenses
|
3.4m
USD
|
Net Income
|
-12.5m
USD
|
Income Statement
Neurobo Pharmaceuticals Inc
Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | |||||||||||||||||||||||||||||||||||
Operating Expenses |
(5)
|
(7)
|
(9)
|
(9)
|
(10)
|
(15)
|
(20)
|
(29)
|
(34)
|
(33)
|
(33)
|
(29)
|
(26)
|
(23)
|
(19)
|
(14)
|
(11)
|
(8)
|
(23)
|
(23)
|
(24)
|
(12)
|
(28)
|
(30)
|
(30)
|
(15)
|
(15)
|
(14)
|
(14)
|
(11)
|
(19)
|
(20)
|
(21)
|
(16)
|
|
Selling, General & Administrative |
(2)
|
(3)
|
(4)
|
(4)
|
(5)
|
(6)
|
(7)
|
(11)
|
(11)
|
(10)
|
(10)
|
(8)
|
(9)
|
(8)
|
(8)
|
(6)
|
(5)
|
(3)
|
(4)
|
(5)
|
(5)
|
(8)
|
(7)
|
(8)
|
(8)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(8)
|
(7)
|
(7)
|
|
Research & Development |
(3)
|
(4)
|
(5)
|
(5)
|
(5)
|
(9)
|
(13)
|
(18)
|
(22)
|
(23)
|
(22)
|
(21)
|
(18)
|
(14)
|
(11)
|
(8)
|
(6)
|
(5)
|
(6)
|
(6)
|
(6)
|
(5)
|
(4)
|
(5)
|
(5)
|
(7)
|
(6)
|
(5)
|
(4)
|
(3)
|
(3)
|
(4)
|
(6)
|
(9)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(13)
|
(13)
|
(13)
|
0
|
(17)
|
(17)
|
(17)
|
0
|
0
|
0
|
0
|
0
|
(8)
|
(8)
|
(8)
|
0
|
|
Operating Income |
(5)
N/A
|
(7)
-49%
|
(9)
-22%
|
(9)
-3%
|
(10)
-14%
|
(15)
-44%
|
(20)
-36%
|
(29)
-43%
|
(34)
-18%
|
(33)
+2%
|
(33)
+1%
|
(29)
+12%
|
(26)
+9%
|
(23)
+13%
|
(19)
+19%
|
(14)
+23%
|
(11)
+25%
|
(8)
+26%
|
(23)
-190%
|
(23)
0%
|
(24)
-3%
|
(12)
+48%
|
(28)
-129%
|
(30)
-5%
|
(30)
-1%
|
(15)
+49%
|
(15)
+3%
|
(14)
+5%
|
(14)
+3%
|
(11)
+17%
|
(19)
-69%
|
(20)
-3%
|
(21)
-4%
|
(16)
+23%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(1)
|
0
|
1
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
(2)
|
0
|
|
Non-Reccuring Items |
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(17)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
8
|
6
|
9
|
11
|
3
|
|
Pre-Tax Income |
(7)
N/A
|
(9)
-36%
|
(9)
+2%
|
(9)
+2%
|
(10)
-15%
|
(15)
-47%
|
(20)
-37%
|
(29)
-46%
|
(34)
-16%
|
(33)
+1%
|
(33)
+1%
|
(29)
+12%
|
(27)
+9%
|
(24)
+12%
|
(20)
+14%
|
(16)
+19%
|
(14)
+16%
|
(21)
-54%
|
(22)
-4%
|
(22)
+2%
|
(21)
+2%
|
(30)
-39%
|
(28)
+5%
|
(30)
-5%
|
(30)
-1%
|
(15)
+49%
|
(15)
+3%
|
(14)
+4%
|
(14)
+2%
|
(14)
-1%
|
(14)
+2%
|
(11)
+19%
|
(12)
-6%
|
(12)
-5%
|
|
Net Income | |||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(7)
|
(9)
|
(9)
|
(9)
|
(10)
|
(15)
|
(20)
|
(29)
|
(34)
|
(33)
|
(33)
|
(29)
|
(27)
|
(24)
|
(20)
|
(16)
|
(14)
|
(21)
|
(22)
|
(22)
|
(21)
|
(30)
|
(28)
|
(30)
|
(30)
|
(15)
|
(15)
|
(14)
|
(14)
|
(14)
|
(14)
|
(11)
|
(12)
|
(12)
|
|
Net Income (Common) |
(9)
N/A
|
(13)
-38%
|
(11)
+19%
|
(10)
+2%
|
(12)
-12%
|
(15)
-30%
|
(20)
-35%
|
(29)
-44%
|
(34)
-16%
|
(33)
+1%
|
(33)
+1%
|
(29)
+12%
|
(27)
+9%
|
(24)
+12%
|
(20)
+14%
|
(16)
+19%
|
(14)
+16%
|
(21)
-54%
|
(22)
-4%
|
(22)
+2%
|
(21)
+2%
|
(30)
-39%
|
(28)
+5%
|
(30)
-5%
|
(30)
-1%
|
(15)
+49%
|
(15)
+3%
|
(14)
+4%
|
(14)
+2%
|
(14)
-1%
|
(14)
+2%
|
(11)
+19%
|
(12)
-6%
|
(12)
-5%
|
|
EPS (Diluted) |
-315
N/A
|
-1 304
-314%
|
-1 050
+19%
|
-1 028
+2%
|
-1 151
-12%
|
-1 495
-30%
|
-2 020
-35%
|
-2 916
-44%
|
-3 388
-16%
|
-3 342
+1%
|
-1 657
+50%
|
-1 466
+12%
|
-1 336.5
+9%
|
-1 182
+12%
|
-1 010.99
+14%
|
-823
+19%
|
-690.49
+16%
|
-125.35
+82%
|
-42.76
+66%
|
-40.18
+6%
|
-38.76
+4%
|
-54.96
-42%
|
-39.25
+29%
|
-40.27
-3%
|
-40.82
-1%
|
-19.84
+51%
|
-16.67
+16%
|
-15.97
+4%
|
-15.58
+2%
|
-5.43
+65%
|
-0.5
+91%
|
-0.27
+46%
|
-0.29
-7%
|
-2.46
-748%
|